|
|||||
|
|
DHX15 is up-regulated in castration-resistant prostate cancer and required for androgen receptor sensitivity to low DHT concentrations |
|
| Authors: | Yadong Xu BS Qiong Song BS Laura E. Pascal PhD Mingming Zhong PhD Yibin Zhou MD Jianhua Zhou BS Fang-Ming Deng MD PhD Jiaoti Huang MD PhD Zhou Wang PhD |
| Affiliation: | 1. Department of Urology, The Second Xiangya Hospital of Central South University, Changsha, China The Third Xiangya Hospital of Central South University, Changsha, China Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania;2. Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania Center for Translational Medicine, Guangxi Medical University, Nanning, China;3. Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania;4. Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania Department of Urology, The Second Affiliated Hospital of Soochow University, Suzhou, China;5. Department of Pathology, NYU School of Medicine, New York, New York;6. Department of Pathology, Duke University School of Medicine, Durham, North Carolina |
| Abstract: | |
| Keywords: | androgen receptor castration resistant prostate cancer DHX15 enzalutamide |